Evidence map›Paper›PMID 38304517›Full record

ArticleJournal of oral and maxillofacial pathology : JOMFP

Langerhans cell expression in oral submucous fibrosis: An immunohistochemical analysis.

Shugufta Shafi, Rubeena Anjum, Mandeep Kaur, Nidhi Khajuria

Open access · hybridAbstract read
In one paragraph

Article in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shugufta ShafiDepartment of Oral and Maxillofacial Pathology and Oral Microbiology, Indira Gandhi Government Dental College, Jammu, Jammu & Kashmir, India.
Rubeena AnjumDepartment of Oral and Maxillofacial Pathology and Oral Microbiology, Indira Gandhi Government Dental College, Jammu, Jammu & Kashmir, India.
Mandeep KaurDepartment of Oral and Maxillofacial Pathology and Oral Microbiology, Indira Gandhi Government Dental College, Jammu, Jammu & Kashmir, India.
Nidhi KhajuriaDepartment of Oral and Maxillofacial Pathology and Oral Microbiology, Indira Gandhi Government Dental College, Jammu, Jammu & Kashmir, India.
Creative Commons · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Langerhans cells (LCs) are dendritic cells (DCs) of the epithelium which play a role in an array of oral lesions from gingivitis to oral cancer. Oral submucous fibrosis (OSMF), a potentially malignant disorder (PMD), is an insidious chronic disease with juxta-epithelial inflammatory changes leading to fibrosis. LCs may play a part in the ongoing inflammatory dysregulation of OSMF. Objective: The study was aimed at elucidating the distribution of LCs in varying grades of OSMF. Materials and Methods: A retrospective study using 18 cases of OSMF, graded using haematoxylin and eosin (H&E)-stained section. Immunohistochemistry was performed using polyclonal anti-CD1a antibodies to identify LCs in six cases of normal tissue and 18 samples of OSMF. The distribution of LCs among the various grades and normal mucosa analysed using Student's t-test. Results: LC population in the OSMF was significantly higher when compared to the normal epithelium (p < 0.001). Within the grades, the advanced stage had more LCs than the other stages. Conclusion: The increase in LCs might indicate the role of antigenic exposure in turn leading to cell-mediated immunity in OSMF. Thus, the fibrosis in OSMF might have a direct link to LCs.

Indexed as

CD1acell-mediated immunitydendritic cell

Identifiers

PMID38304517
PMCPMC10829435
OpenAlexW4390056380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.